Company intelligence / Profile preview

Equinamitas

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Equinamitas is a geroscience-focused biotechnology company dedicated to developing therapeutics that target the fundamental biology of aging to extend human healthspan. Founded by a team of world-renowned experts in aging research, the company operates as a venture studio and company builder, identifying and advancing high-potential longevity science from academia into clinical development. Equinamitas focuses on a broad range of age-related indications, leveraging its founders' expertise in areas such as senolytics, metabolic health, and regenerative medicine. The company aims to create a portfolio of subsidiaries, each targeting specific mechanisms of aging to address the root causes of chronic diseases.

Therapeutic areas: OtherMetabolic Disorders
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Equinamitas.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Equinamitas.

Explore the full profile